Related Topics

Newsletter

LinkedIn
Vimeo
Facebook

FSHD

FSH muscular dystrophy

Genea Biocells developed the world’s first human stem cell model of FSHD which shows cellular hallmarks of the disease. We pursue a small molecule approach to find therapeutic drug candidates that slow, stop or reverse the disease-related phenotype in skeletal muscle.  This project has been supported by the FSHD Global Research Foundation and Friends of FSH Research.

About FSHD

FSHD is a genetic disease resulting in progressive muscle weakness

Onset is typically in young adults

Affects ~1:7-8,000 people

FSHD is caused by aberrant upregulation of DUX4 – a protein toxic to muscle

For more information on FSHD visit the   → MDA website 

Social media & sharing icons powered by UltimatelySocial